On-treatment lung immune prognostic index is predictive for first-line PD-1 inhibitor combined with chemotherapy in patients with non-small cell lung cancer

BACKGROUND: Inflammation is a factor that promotes tumor progression and immunosuppression. Lung immune prognostic index (LIPI) is a non-invasive and easily calculated indicator of inflammation. This study aimed to investigate whether continuous assessment of LIPI has predictive value for chemoimmun...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiong, Anning, Xu, Jianlin, Wang, Shuyuan, Zhong, Runbo, Lu, Jun, Chu, Tianqing, Zhang, Wei, Li, Ying, Zheng, Xiaoxuan, Han, Baohui, Nie, Wei, Zhong, Hua, Zhang, Xueyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10247997/
https://www.ncbi.nlm.nih.gov/pubmed/37304273
http://dx.doi.org/10.3389/fimmu.2023.1173025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10247997/
https://www.ncbi.nlm.nih.gov/pubmed/37304273
http://dx.doi.org/10.3389/fimmu.2023.1173025

Ejemplares similares